Department of Cardiology, siyami Ersek Cardiovascular and Thoracic Surgery Center, Istanbul, Turkey.
Clin Interv Aging. 2013;8:1051-4. doi: 10.2147/CIA.S47121. Epub 2013 Aug 7.
To evaluate the complication rate differences between elderly and younger patients who receive a permanent pacemaker implantation.
We reviewed all cases admitted to our institution between January 2008 and June 2009 with symptomatic bradyarrhythmia for whom a permanent pacemaker was implanted. Beginning in June 2009, we prospectively collected data from all patients with the same diagnosis and procedure. The frequency of complications due to the pacemaker implantation procedure was evaluated and compared between young (<70 years old) and elderly (≥70 years old) patients.
Among 574 patients with a permanent pacemaker, 259 patients (45.1%) were below and 315 patients (54.9%) were above or at 70 years of age. There were 240 (92.7%) and 19 (7.3%) dual-chamber pacemaker (DDD) and single-chamber pacemaker (VVI) implanted patients in the younger group, and 291 (76.8%) and 73 (23.2%) DDD and VVI pacemaker implanted patients in the elderly group, respectively. The complication rate was 39 (15.1%) out of 259 young patients and 24 (7.6%) out of 315 elderly patients. Postprocedural complications were statistically lower in the elderly patients than in younger patients (P = 0.005).
A pacemaker implantation performed by an experienced operator is a safe procedure for patients of advanced age. The patients who are above 70 years old may have less complication rates than the younger patients.
评估接受永久性心脏起搏器植入的老年和年轻患者之间并发症发生率的差异。
我们回顾了 2008 年 1 月至 2009 年 6 月期间因症状性心动过缓而在我院接受永久性心脏起搏器植入的所有病例。自 2009 年 6 月起,我们前瞻性地收集了具有相同诊断和手术的所有患者的数据。评估并比较了年轻(<70 岁)和老年(≥70 岁)患者之间因起搏器植入手术引起的并发症的频率。
在 574 例永久性心脏起搏器患者中,259 例(45.1%)年龄<70 岁,315 例(54.9%)年龄≥70 岁。年轻组中 240 例(92.7%)和 19 例(7.3%)植入双腔起搏器(DDD)和单腔起搏器(VVI),老年组中 291 例(76.8%)和 73 例(23.2%)植入 DDD 和 VVI 起搏器。年轻患者中并发症发生率为 39 例(15.1%),老年患者中为 24 例(7.6%)。老年患者的术后并发症发生率明显低于年轻患者(P=0.005)。
由经验丰富的医生进行的起搏器植入术对于高龄患者是一种安全的手术。年龄在 70 岁以上的患者可能比年轻患者的并发症发生率低。